Mini-reviewRegulation of intestinal cancer stem cells
Section snippets
Normal and ’cancer’ stem cells
Normal adult tissue stem cells are a population of relatively immature cells capable of self-renewal and differentiation which are vital for tissue homeostasis. In the large intestine, the stem cell population resides at the base of the crypt and gives rise to the three major cell lineages present in the colon, namely enterocyte, endocrine and goblet cells. Intestinal stem cells are constantly renewing the intestinal epithelium so that there is a general flow of cells from the lower toward the
Regulation of CSCs: the Wnt pathway
The canonical Wnt pathway has long been recognised as an important regulator of normal intestinal stem cells [33], and more recently as a regulator of colon CSCs [34]. In the absence of sufficient Wnt signalling, cytosolic β-catenin is targeted for proteosomal degradation following casein kinase 1 (CK1) and glycogen synthase 3 (GSK3) mediated phosphorylation. Both kinases reside in a large complex with the scaffolding proteins APC and Axin-1. Extracellular Wnt ligands bind to the frizzled cell
Methylation of stem cell associated genes in cancer
Two gene signatures derived independently from either EPHB2 high or Wnt high stem cells were found to predict poor prognosis in patients [25], [32]. However rather provocatively, the Medema group showed that elevated expression of Wnt targets, including stem cell markers such as LGR5 and ASCL2, was found to be associated with good prognosis [25]. Further analysis indicated that many Wnt target genes were silenced by CpG island methylation during late development. Re-expression of silenced genes
Notch signalling
Notch is another important signalling pathway involved in regulating intestinal stem cells [63]. There are four Notch genes in mammals, which act as receptors for Jagged 1 and 2, and Delta Like (Dll) 1,3 and 4. Ligand binding to Notch results in its cleavage by γ-secretase to release the intracellular domain of Notch (NICD). NICD then translocates to the nucleus where it interacts with CBF1/RBPJ-κ to activate transcription of Notch target genes such as HES-1, -5, -7, Hey-1, Hey-2, HEYL [64].
Bone morphogenic proteins
Whilst Notch and Wnt signalling have been the main focus of research in CSC regulation, a number of other pathways have also been implicated. The Bone Morphogenic Proteins (BMPs) are multi-functional growth factors belonging to the TGFβ superfamily which have been found to influence intestinal stem cell differentiation. BMPR1 intestinal conditional knock-out mice develop multiple intestinal polyps, due to enhanced Wnt signalling and proliferation of stem cells [81]. Comparison of gene
MicroRNA and epigenetic regulation of CSCs
Some studies have begun to outline the role of microRNAs (miRNA) in regulation of CSCs. MiRNAs are small RNA molecules capable of suppressing mRNA expression. A comparison of the miRNA levels pattern of developing embryonic tissue with that of adult colorectal cancer showed a marked overlap, but not with paired non-cancerous colon tissue [83]. Members of the miR-17-92 cluster were part of this overlapping group, and inhibition of miR-17-5p reduced DLD1 cancer cell proliferation and
Influence of the tumour environment on CSCs
As well as intrinsic factors, extrinsic signalling is believed to be vital in the regulation of normal stem cells and CSCs. Normal intestinal stem cells are in close proximity to surrounding stromal cells which include myofibroblasts and smooth muscle cells, and are in close proximity to the basement membrane [86], [87]. This stromal environment is believed to form a niche that maintains the stem cell compartment [88]. In the mouse small intestine Paneth cells have been implicated in forming
Conclusions
Human colorectal cancer stem cells, as with their normal counterparts, exhibit complex regulatory mechanisms, including the Wnt, BMP and Notch pathways, and are capable of differentiation as well as self-renewal. The local tissue environment and stroma also play key roles in regulating stem cell growth in vivo, which is an area likely to be of great interest for future research. Targeting these factors will be useful for preventing tumour growth by altering the balance between self-renewal and
References (100)
- et al.
Heterogeneity of cancer cells from a single human colon carcinoma
Am. J. Med.
(1981) - et al.
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases
Cell Stem Cell
(2011) - et al.
The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse
Cell Stem Cell
(2011) - et al.
On the proportion of cancer stem cells in a tumour
J. Theor. Biol.
(2010) - et al.
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
Cell Stem Cell
(2007) - et al.
Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan
Gastroenterology
(2011) - et al.
A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer
Cell Stem Cell
(2010) - et al.
Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin
Gastroenterology
(2004) - et al.
Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB
Cell
(2002) - et al.
SOX9 is required for the differentiation of paneth cells in the intestinal epithelium
Gastroenterology
(2007)